Cargando…
Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier
Over the past decades, a frequent co-morbidity of cerebrovascular pathology and Alzheimer’s disease has been observed. Numerous published studies indicate that the preservation of a healthy cerebrovascular endothelium can be an important therapeutic target. By incorporating the appropriate drug(s) i...
Autor principal: | D’Arrigo, Joseph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352688/ https://www.ncbi.nlm.nih.gov/pubmed/31105226 http://dx.doi.org/10.3390/biomimetics3010004 |
Ejemplares similares
-
Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades
por: D’Arrigo, Joseph S.
Publicado: (2020) -
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
por: Khan, Mohammad Sameer, et al.
Publicado: (2023) -
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers
por: Caprifico, Anna E., et al.
Publicado: (2020) -
Effects of Cations on the Behaviour of Lipid Cubic Phases
por: Brasnett, Christopher, et al.
Publicado: (2017) -
Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting
por: D’Arrigo, Joseph S.
Publicado: (2017)